Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

L Klimek1, A M Chaker2, M Cuevas3

  • 1Zentrum für Rhinologie und Allergologie, Wiesbaden.

Laryngo- Rhino- Otologie
|February 1, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graphene-plasmon-mediated coherent dynamics in an N-quantum-emitter system.

Optics express·2026
Same author

Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps.

Allergy·2026
Same author

[Use of Omalizumab-biosimilars for CRSwNP in the German Health Care System - a Position Paper of the German Societies for Allergy AeDA and ORL DGHNO-KHC].

Laryngo- rhino- otologie·2026
Same author

Correspondence: First Peanut (Arachis hypogaea) Allergen Oral Immunotherapy Product Out of Sale-A Major Drawback for Food Allergy Immunotherapy?

Allergy·2026
Same author

[Different immunological types of CRSwNP in the context of the new European EAACI nomenclature : Part 3: Hypersensitivity reactions of type VI].

HNO·2026
Same author

The Unmet Need of Olfactory Testing in Inflammatory Disorders of the Upper Airways-An EAACI Position Paper.

Allergy·2026
Same journal

Guideline-Based Cochlear Implant Care: A Model for Structuring Delegated Technical Aftercare.

Laryngo- rhino- otologie·2026
Same journal

Audiometric evaluation and quality-of-life in OSIA users - a retrospective monocentric study.

Laryngo- rhino- otologie·2026
Same journal

[Diagnosis and treatment of vestibular migraine - recent developments and future treatment strategies].

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
Same journal

Laryngo- rhino- otologie·2026
See all related articles

This review covers various COVID-19 vaccine technologies, including RNA, subunit, and viral vector platforms. It also discusses rare allergic reactions and the importance of future pandemic preparedness with innovative vaccine development.

Area of Science:

  • Immunology and Virology
  • Vaccinology
  • Infectious Disease Prevention

Background:

  • The COVID-19 pandemic necessitated rapid vaccine development.
  • Multiple vaccine platforms have been successfully deployed globally.
  • Vaccines are crucial for preventing infectious diseases.

Purpose of the Study:

  • To review the characteristics, biology, and pharmacology of diverse vaccine platforms.
  • To discuss reported allergic reactions and immune phenomena associated with vaccines.
  • To highlight the strategic importance of innovative vaccine technology for future pandemic preparedness.

Main Methods:

  • Review of scientific literature on vaccine technologies.
  • Analysis of data on vaccine efficacy and safety.

Related Experiment Videos

  • Discussion of pharmacological and biological aspects of different vaccine types.

    • Main Results:

    • Several vaccine platforms, including RNA, subunit, inactivated, attenuated, VLP, and adenoviral vectors, are available.
    • Allergic reactions to vaccines and their components are uncommon but require documentation.
    • Skin-prick testing can identify allergies to vaccine components like PEGs.

    Conclusions:

    • Diverse vaccine technologies have been rapidly developed and implemented.
    • Continued monitoring of vaccine side effects and immune responses is essential.
    • Advancing vaccine technology and antiviral medications are key for future pandemic preparedness.